|
Adebelizumab+Carboplatin+Etoposide+Concurrent Radiotherapy Clinical Trials
1 actively recruiting trial
Also known as: Adebelizumab Combined With Chemotherapy and Sequential Adebelizumab Combined With Radiotherapy in the Treatment of Newly Diagnosed Extensive Small Cell Lung Cancer
Pipeline
Phase 2: 1
Top Sponsors
- Qianfoshan Hospital1
Indications
- Extensive Small Cell Lung Cancer1
- Lung Cancer1
- Cancer1
Other1 trial
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.